 Legal General Group Plc trimmed its holdings in Aimmune Therapeutics Inc NASDAQ:AIMT by 6.6 in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 30,066 shares of the biotechnology companys stock after selling 2,114 shares during the period. Legal ... 